Hashimoto, S., Furukawa, S., Hashimoto, A., Tsutaho, A., Fukao, A., Sakamura, Y., . . . Sabe, H. (2019). ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer. Proc Natl Acad Sci U S A.
استشهاد بنمط شيكاغوHashimoto, Shigeru, et al. "ARF6 and AMAP1 Are Major Targets of KRAS and TP53 Mutations to Promote Invasion, PD-L1 Dynamics, and Immune Evasion of Pancreatic Cancer." Proc Natl Acad Sci U S A 2019.
MLA استشهادHashimoto, Shigeru, et al. "ARF6 and AMAP1 Are Major Targets of KRAS and TP53 Mutations to Promote Invasion, PD-L1 Dynamics, and Immune Evasion of Pancreatic Cancer." Proc Natl Acad Sci U S A 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.